Dimensional Fund Advisors’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Dimensional Fund Advisors’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$17K	Buy	+335	New	+$23.3K	﹤0.01%	3467

Other funds holding FNCH

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

AMC

Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

TRB Advisors New York $233M AUM 14.81% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Dimensional Fund Advisors's FNCH Position: Q3 2022 in Review

Dimensional Fund Advisors opened a new position in Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q3 2022: 335 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #3467 among its holdings.

43 funds tracked by Wall St. Rank hold FNCH as of Q3 2022.

Dimensional Fund Advisors held 335 shares of Finch Therapeutics Group, Inc. Common Stock worth $17K as of Q3 2022.
Finch Therapeutics Group, Inc. Common Stock was a new Dimensional Fund Advisors position in Q3 2022.
Finch Therapeutics Group, Inc. Common Stock made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3467 holding.
43 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.